AngioDynamics is a leading provider of innovative medical devices used by interventional radiologists, interventional cardiologists, surgeons, and other physicians for the minimally-invasive diagnosis and treatment of cancer and peripheral vascular disease. Founded in Queensbury in 1988, AngioDynamics and has grown into a NASDAQ-listed public company. Having distinguished itself as a dynamic brand in a technologically competitive, high-growth industry, AngioDynamics sells its products in the U.S. through a direct sales force, and in international markets through a combination of direct sales and distributors. Source
No articles found.
Celldex is developing targeted therapeutics to address devastating diseases for wh...
Celldex is developing targeted therapeutics to ...
Organovo is a biotech platform company that has developed a leadership position wi...
Organovo is a biotech platform company that has...
Oncolytics is focused on obtaining regulatory approval for pelareorep for metastat...
Oncolytics is focused on obtaining regulatory a...
Founded in 1941 in Tokyo, Japan, Hoya is a global med-tech company, and a leading ...
Founded in 1941 in Tokyo, Japan, Hoya is a glob...
Join the National Investor Network and get the latest information with your interests in mind.